Signs of Cross-Reactivity Between SARS-CoV-2 and Other Coronaviruses in a Pre-Vaccine Swedish School SettingShow others and affiliations
2026 (English)In: Acta Paediatrica, ISSN 0803-5253, E-ISSN 1651-2227Article in journal (Refereed) Epub ahead of print
Abstract [en]
Aim This pilot study explored signs of immunological cross-reactivity between SARS-CoV-2 and human coronaviruses (HCoVs) in a Swedish school setting.Methods A cross-sectional, hypothesis-generating study was conducted late 2020 before vaccines against COVID-19 were available. Forty-seven 7-8-year-old children, seventy-five 14-year-old adolescents, fifty-four 17-year-old adolescents, and 52 adult school staff were included, and immune responses to SARS-CoV-2 and HCoVs were assessed.Results The SARS-CoV-2 seroprevalence was high in the older age groups (33%-41%). Seropositive individuals had significantly higher levels of antibodies against betacorona virus compared to seronegative individuals. SARS-CoV-2 seropositivity was rare among the 7-8-year-old children despite the high endemic context. SARS-CoV-2-specific T-cell responses in the absence of SARS-CoV-2-specific antibodies were seen in all age groups.Conclusion The data support a role for cross-reactive immune responses induced by recent HCoV infections, with cross-reactive T-cell responses providing protection against COVID-19 in young children.
Place, publisher, year, edition, pages
WILEY , 2026.
Keywords [en]
children; COVID-19; immune response; SARS-CoV-2; school
National Category
Pediatrics
Identifiers
URN: urn:nbn:se:liu:diva-222781DOI: 10.1111/apa.70532ISI: 001731927800001PubMedID: 41934365Scopus ID: 2-s2.0-105034931732OAI: oai:DiVA.org:liu-222781DiVA, id: diva2:2052675
Note
Funding Agencies|Swedish Government [S2020/02681/FS, S2020-11-19 S2020/08532]
2026-04-142026-04-142026-06-27